Targeting HSP90 in malignant gliomas: onalespib as a potential therapeutic
Transl Cancer Res
.
2018 Apr;7(4):6215-6226.
doi: 10.21037/tcr.2018.03.05.
Authors
Naomi Lomeli
1
,
Daniela A Bota
1
2
3
4
Affiliations
1
Department of Pathology & Laboratory Medicine, University of California Irvine, Irvine, CA, USA.
2
Department of Neurology, University of California Irvine, Irvine, CA, USA.
3
Department of Neurological Surgery, University of California Irvine, Irvine, CA, USA.
4
Chao Family Comprehensive Cancer Center, University of California Irvine, Irvine, CA, USA.
PMID:
31840022
PMCID:
PMC6910236
DOI:
10.21037/tcr.2018.03.05
No abstract available
Publication types
Comment
Grants and funding
K08 NS072234/NS/NINDS NIH HHS/United States
P30 CA062203/CA/NCI NIH HHS/United States
UL1 TR001414/TR/NCATS NIH HHS/United States